Search filters

List of works by Malayannan Subramaniam

Development, characterization, and applications of a novel estrogen receptor beta monoclonal antibody

scientific article published on February 2012

ERβ-mediated induction of cystatins results in suppression of TGFβ signaling and inhibition of triple-negative breast cancer metastasis

article published in the Proceedings of the National Academy of Sciences of the United States of America

ERβ1: characterization, prognosis, and evaluation of treatment strategies in ERα-positive and -negative breast cancer

scientific article

Endoxifen's molecular mechanisms of action are concentration dependent and different than that of other anti-estrogens

scientific article

Enhancer of Zeste Homolog 2 Inhibition Stimulates Bone Formation and Mitigates Bone Loss Caused by Ovariectomy in Skeletally Mature Mice

scientific article published on 10 October 2016

Estrogen receptor beta repurposes EZH2 to suppress oncogenic NFκB/p65 signaling in triple negative breast cancer

scientific article published on 17 February 2022

Estrogen receptor-beta sensitizes breast cancer cells to the anti-estrogenic actions of endoxifen

scientific article published on 10 March 2011

Novel role of Tieg1 in muscle metabolism and mitochondrial oxidative capacities

scientific article published on 19 October 2019

Optimized immunohistochemical detection of estrogen receptor beta using two validated monoclonal antibodies confirms its expression in normal and malignant breast tissues

scientific article published on 30 September 2019

Runx2 protein represses Axin2 expression in osteoblasts and is required for craniosynostosis in Axin2-deficient mice

scientific article published on 7 January 2013

Skeletal and Uterotrophic Effects of Endoxifen in Female Rats

scientific article

TIEG1/KLF10 modulates Runx2 expression and activity in osteoblasts

scientific article

The effects of a novel hormonal breast cancer therapy, endoxifen, on the mouse skeleton

scientific article (publication date: 2014)

The tamoxifen metabolite, endoxifen, is a potent antiestrogen that targets estrogen receptor alpha for degradation in breast cancer cells

scientific article

Paulina is supported by:

About Paulina

Help